Clinical Trial: Combination of Letrozole Plus Abemaciclib in Estrogen Receptor–Positive Endometrial Cancer
Does abemaciclib and letrozole effective slow or stop endometrial cancer cell growth?
All articles by Cancer Therapy Advisor Staff
Clinical Trial: Mirvetuximab Soravtansine and Pembrolizumab in Endometrial Cancer
All patients will receive mirvetuximab soravtansine and pembrolizumab in this study.
Trial to Evaluate PORTEC-4a: Molecular Profile-Based vs Standard Adjuvant Radiotherapy in Endometrial Cancer
A phase 3 study seeks to evaluate the value of selecting therapy based on molecular profiling.
Clinical Trial: Phase 3 AtTEnd Trial in Endometrial Cancer
Patients with advanced or recurrent endometrial cancer enrolled in the experimental arm will receive atezolizumab in combination with paclitaxel and carboplatin.
Clinical Trial: Evaluating Bioactivity in Breast Cancer Tumor Tissue After Intratumoral Administration of PVSRIPO
The objective of the study is to investigate PVSRIPO-mediated inflammation and immunity in women invasive breast cancer.
Trial Aims to Increase Breast Cancer Screening Rates in African Immigrants Living in the United States
Barriers to breast cancer screening for certain minority groups have been studied, but less is known about the barriers for African immigrant women.
Trial to Evaluate Safety and Efficacy After Omission of Sentinel Node Biopsy in Estrogen-Positive Breast Cancer
Enrolled patients will undergo standard of care lumpectomy without sentinel node biopsy followed by radiation and hormonal therapy.
Trial to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer
A phase 1b/2 study seeks to determine whether sacituzumab govitecan will stop or slow the growth of metastatic breast cancer.
The 2020 Gastrointestinal Cancers Symposium: What to Expect
Cancer Therapy Advisor’s coverage of the Gastrointestinal Cancers Symposium will reflect the theme of personalized care across multiple types of gastrointestinal cancers.
Phase 1b/2 Trial Assessing Cirmtuzumab With Ibrutinib in Patients With B-Cell Lymphoid Malignancies
Part 1 of the trial is a dose-finding evaluation of the sequential administration of cirmtuzumab monotherapy followed by cirmtuzumab and ibrutinib combination.
-
Loading...
-
Loading...
